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 Durable Medical Equipment and Medical 
Supplies — Measures to Control Costs 
Need Strengthening 
What questions was this OPEGA review intended to answer? 
• Does the State have effective systems to control and contain costs associated with 
durable medical equipment and medical supplies (DME) purchased through 
MaineCare?  If not, why not? 
 
What was OPEGA’s overall conclusion? 
Existing measures for preventing and detecting excessive, unnecessary or inappropriate 
claims need to be strengthened to more effectively control costs and better support 
DHHS’ cost containment initiatives for MaineCare DME.  As a result of issues identified, 
the State is not realizing the full benefit of its cost containment efforts.   
OPEGA’s analysis of DME claims identified $115,900.70 in potential overpayments or 
unnecessary expenditures during fiscal year 2008 (FY08) due to one or a combination of 
ineffective controls.  We roughly estimate that there could be an additional $229,000 in 
overpayments related to those same issues that have occurred between July 1, 2008 and 
June 30, 2009. 
In addition, we identified numerous situations that appeared to present risk of fraud or 
unnecessary expenditures.  Fifty of these situations have been shared with DHHS and are 
being researched by the Program Integrity Unit and Office of MaineCare Services to 
determine whether any actual losses have occurred. 
What actions has OPEGA recommended? 
OPEGA recommended the Department take action to: 
? Strengthen the Program Integrity Unit’s capacity to monitor MaineCare claims. 
? Ensure communication and action on issues identified by the Program Integrity Unit. 
? Better correlate units of measure on billed quantities with allowed rates.  
? Establish contracted rates for items covered by bulk purchasing agreements in the 
claims system Rate Tables. 
? Address irregularities in Rate Tables that allow vendors to be reimbursed at higher 
rates than intended. 
? Research questionable claims activity identified by OPEGA. 
? Investigate possible additional overpayments on incontinence supplies. 
? Proactively address procedure codes in Rate Tables with $0 reimbursement rates 
? Correct programming error that allowed payment of claims after the prior 
authorization had been voided.   
 
To get a copy of the 
full report, or for more 
information visit the 
website listed at the 
bottom of this page or 
contact OPEGA at 
(207)287-1901. 
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MaineCare Durable Medical Equipment and Medical Supplies 
FULL REPORT 
Durable Medical Equipment and Medical Supplies — Measures to 
Control Costs Need Strengthening 
Purpose  ――――――――――――――――――――――――――――――――――― 
The Maine Legislature’s Office of Program Evaluation and Government 
Accountability (OPEGA) has completed a review of durable medical equipment 
and medical supplies provided by the Department of Health and Human Services 
(DHHS) through MaineCare.  OPEGA conducted this review at the direction of 
the joint legislative Government Oversight Committee (GOC) of the 123rd 
Legislature, in accordance with 3 MRSA §§991-997.  
Government Oversight Committee members, as well as other legislators, had 
expressed interest in whether sufficient measures were being taken to prevent, 
detect, and correct instances of fraud or unnecessary expenditure and, otherwise, to 
contain costs associated with MaineCare programs.  OPEGA suggested durable 
medical equipment and medical supplies (DME)1 as one possible area of focus 
after researching recent Medicaid program reviews conducted by other states and 
the U.S. Government Accountability Office.  DHHS was also supportive of an 
OPEGA review in this area as the Department was interested in identifying more 
possibilities for containing DME costs. 
OPEGA’s review, as approved by the GOC, focused on whether the State has 
effective systems to control and contain costs associated with claims for durable 
medical equipment and medical supplies purchased through MaineCare.  DME 
claims paid in fiscal year 2008 (FY08) totaled $18.9 million.  Approximately $15.6 
million was processed through the Maine Claims Management System (MECMS).  
The remainder, approximately $3.3 million in claims originating from pharmacies, 
was processed through the Maine Pharmacy Point of Purchase System (MEPOPS). 
Scope and Methods ―――――――――――――――――――――――――――― 
The scope of our review 
was generally limited to 
claims for DME paid 
through MECMS during 
FY08.   
OPEGA sought to 
determine whether the 
State has effective 
systems for controlling 
MaineCare costs 
associated with durable 
medical equipment and 
medical supplies. 
The scope of the review was generally limited to claims and cost-containment 
efforts associated with DME paid through MECMS in FY08.  OPEGA’s work 
included: 
                                                 
1 For the purpose of the report, the acronym DME will refer to both durable medical 
equipment and medical supplies. 
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• interviewing management and staff associated with DHHS’s Office of 
MaineCare Services (OMS), Program Integrity Unit and Rate Setting Unit;  
• reviewing pertinent State and federal regulations, including the MaineCare 
Benefits Manual; 
• reviewing reports and work plans from similar audits done in other states; 
and 
• reviewing State Single Audit Reports and obtaining additional information 
from the State Auditor. 
In addition, we obtained and analyzed an extract of claims paid through MECMS in 
FY08.  This extract included all DME claims as well as all other claims paid in 
FY08 (services or goods) for any MaineCare members who had DME claims 
within our time period.  The claim data was analyzed for questionable transactions 
and unusual patterns that indicated potential fraudulent or unnecessary 
expenditures.   
OPEGA did not learn about the DME claims processed through MEPOPS until 
part-way through the review.  As shown in Table 1, MEPOPS claims constituted 
about 17% of the total dollars spent on DME in FY08.  Given the time-consuming 
nature of the analysis work already underway, it was decided not to take the extra 
steps necessary to include MEPOPS claims in our review.  We do, however, 
encourage DHHS to apply recommendations made in this report to claims 
processed through MEPOPS as appropriate. 
Table 1: Dollar Amounts for Paid Claims By System 
Claims Processed Through Paid Claims (millions, rounded) 
MECMS $15.60  
MEPOPS $  3.30  
Total Claims  $18.90  
Source:  Advantage ME data from the State’s data warehouse 
Background ――――――――――――――――――――――――――――――――― 
Overview of Durable Medical Equipment and Medical Supplies 
Durable medical 
equipment and medical 
supplies are intended to 
treat, control, relieve or 
improve a medical 
condition.  Examples of 
these items include 
bandages, rubber gloves, 
wheelchairs and crutches.  
We conducted research 
that included interviews 
with DHHS and review of 
pertinent State and 
federal regulations.  We 
also analyzed MECMS 
claims data for FY08.  
This review focused on two categories of goods—medical supplies and durable 
medical equipment—provided through MaineCare and intended to treat, control, 
relieve or improve a medical condition.  Chapter II, Section 60 of the MaineCare 
Benefits Manual lists durable medical equipment and medical supplies and specifies 
whether or not their costs are covered by the MaineCare program. 
The MaineCare Benefits Manual defines medical supplies as those goods that are 
primarily needed to relieve or treat a medical condition.  They are generally 
disposable or have a limited number of uses.  Examples include bandages, syringes, 
rubber gloves and incontinence supplies. 
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Conversely, durable medical equipment covered by MaineCare must meet all four 
of the following criteria: 
• Equipment that can withstand repeated use. 
• Primarily used to serve a medical purpose, is medically necessary, and 
reasonable for the treatment of the member’s illness or injury or to improve 
an altered body function. 
Two of the other offices 
with some responsibilities 
related to controlling 
MaineCare costs are the 
Rate Setting Unit and the 
Program Integrity Unit, 
which is an audit function. 
The Office of MaineCare 
Services works in concert 
with other DHHS offices to 
manage the delivery of 
MaineCare-funded 
services. 
MaineCare members get 
doctor’s prescriptions for 
medically necessary DME.  
Those prescriptions are 
filled by vendors enrolled 
in the MaineCare 
program. 
• Not generally useful to a person in the absence of illness or injury. 
• Appropriate for use in the home and is in safe and reasonably good 
condition and suitable for its intended use. 
Examples of durable medical equipment include wheelchairs, crutches, hospital 
beds and prosthetics. 
To obtain durable medical equipment or medical supplies through MaineCare, 
individuals must first meet the eligibility requirements of the MaineCare program 
and then obtain a doctor’s prescription for any items deemed medically necessary.  
Prescriptions are then brought to vendors enrolled in MaineCare to be filled with 
items the vendors have purchased from manufacturers. 
MaineCare programs and benefits encompass the federal Medicaid Program and 
State Children’s Health Insurance Program (SCHIP).  DHHS’ Office of MaineCare 
Services (OMS), formerly the Bureau of Medical Services, has responsibility for the 
Medicaid Plan, the promulgation of rules and the oversight of the traditional 
medical services.  OMS works in concert with the other DHHS offices to manage 
the delivery of MaineCare-funded services in an efficient and effective way. 
As illustrated in Figure 1, there are also other DHHS offices outside of OMS with 
responsibilities related to controlling MaineCare costs.  These include the Rate 
Setting Unit and the Program Integrity Unit, which is an audit function formerly 
known as the Surveillance and Utilization Review Unit.  Both are located within the 
Division of Audit for MaineCare and Social Services under the Deputy 
Commissioner of Financial Services. 
Figure 1. Excerpted DHHS Organizational Chart
Department of Health and Human Services
Financial Management 
Services
Integrated Services
Division of Audit
Program Integrity Unit
Rate Setting Unit
Office of  MaineCare 
Services
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The Program Integrity Unit (PIU) assists in maintaining the integrity of the 
MaineCare program through discovering, pursuing, and preventing fraud; seeking 
reimbursement for overpayments; and providing a deterrent to future fraud.  The 
Rate Setting unit works with OMS to determine reimbursement rates and to 
develop and implement financial policies and procedures in regards to 
methodologies for determining those rates.  
DME Claims Processing 
Vendors get reimbursed for DME they have provided to MaineCare members by 
submitting claims through the State’s current claims processing system, MECMS.  
Vendors provide key information including, but not limited to: the member’s 
MaineCare ID, procedure code, item description, quantity provided and the total 
amount claimed for reimbursement. 
Vendors submit DME 
claims for reimbursement 
through MECMS.  The 
MaineCare Benefits 
Manual specifies what 
cost bases the vendor can 
use in calculating the 
claim amount which is 
generally the lowest of 
four different costs. 
Procedure codes are used by Medicare and Medicaid programs and are monitored 
by the federal Centers for Medicare and Medicaid Services (CMS).  Every service 
and product, including durable medical equipment and medical supplies, are 
represented by a procedure code.  These codes define the product and unit of 
measure, and correlate to a set reimbursement rate which is used in the 
determination of the maximum payment amount. The codes are uniform and 
generic in nature such that one procedure code could possibly be used in claims for 
many brands and sizes of a specific product purchased from any vendor.  
Per the MaineCare Benefits Manual, the rate used by the vendor to calculate the 
requested reimbursement should be lowest of the following: 
• The adjusted acquisition cost plus an allowed forty percent mark up not to 
exceed $2,000.  The adjusted acquisition cost is the net cost of the item 
after deducting for any quantity discounts and exclusive of any shipping, 
freight, handling, and insurance costs.  Prompt payment discounts received 
by the vendor from the manufacturer are not deducted from the acquisition 
cost.  
• The vendor's usual and customary charge. 
• The manufacturer's suggested retail price for any medical supply or durable 
medical equipment (including replacement parts). 
• The maximum MaineCare amount published at least annually on the 
Department’s website, and made available to vendors. 
To ensure compliance with the rules for vendor billing, the Department may at any 
time require proof of the vendor’s cost in the form of an invoice from the 
manufacturer. 
In general, MaineCare does not pay more than an allowed maximum amount that is 
calculated based on established MaineCare and Medicare rates regardless of what 
the vendor claims for reimbursement.  The MaineCare and Medicare rates are 
contained in a MECMS Rates Table and they are based on a unit of measure 
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specified in the Procedure Code description.  MECMS determines what amount to 
pay on a DME claim by applying the allowed MaineCare and Medicare rates for the 
applicable DME item to the quantity billed by the vendor.  The system then pays 
the claim at the lowest of the calculated MaineCare amount, the calculated 
Medicare amount or the vendor’s billed amount. Figure 2 shows an example of this 
calculation.  OPEGA noted that the effectiveness of this control is diminished 
because billed quantities are not always in the same unit of measure that the 
maximum allowed rates are based on.  See Recommendation 3 for more discussion. 
MECMS calculates a 
maximum allowed 
reimbursement amount 
based on established 
MaineCare and Medicare 
rates and generally will 
not pay more than this 
amount regardless of 
what the vendor has 
claimed. 
Procedure Code:   K0052            Description:   Swingaway Detachable Footrest
Number of Units:   2                     Total Claim for Reimbursement:   $138.60
Procedure Code MaineCare Rate              Medicare Rate
K0052 $78.57 $92.44
DME Claim 
from 
Vendor
MECMS 
Rate Table
x x
MaineCare Total 
$157.14
Medicare Total 
$184.88
Vendor’s Total 
Claim $138.60
LOWEST OF THESE AMOUNTS IS PAID TO VENDOR
$138.60
Figure 2.  How MECMS Determines the Payable Amount for Each Claim
 
The maximum Medicare rate is provided by CMS via an annual data feed through 
which the rates are uploaded to the MECMS Rate Tables.  If the data feed contains 
Medicare rates for newly covered or defined products (i.e. new procedure codes) 
then the related MaineCare rate is automatically set by MECMS as a percentage of 
the Medicare rate.  MaineCare rates for already established procedure codes 
typically stay the same, regardless of any updates to the Medicare rates, unless 
DHHS has negotiated prices with a manufacturer under a bulk purchasing contract.  
In these instances, the maximum MaineCare rate for an item would be based on the 
contracted rate.  OPEGA found that MaineCare rates in the MECMS Rate Tables 
were not always updated to reflect the new contracted rates on bulk purchase 
agreements.  See Recommendation 4 for further discussion. 
In some instances, MaineCare rates exceed the Medicare rate and claims are paid at 
the higher MaineCare rate.  This occurs when the Office of MaineCare Services 
must adjust rates appropriately to ensure that members have access to certain 
medical supplies or durable medical equipment.  In these instances, MECMS is 
programmed to default to the MaineCare rate in determining the maximum allowed 
reimbursement amount. 
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Problems with MECMS have been well-documented since its implementation in 
2005 and have never been fully resolved.  As a result, in March 2010, the 
Department will transition to a third-party administrator for processing MaineCare 
claims and MECMS will be replaced with the Maine Integrated Health 
Management Solution (MIHMS).  MIHMS will be an adaptation of an existing 
system already certified by the Centers for Medicare and Medicaid Services (CMS).  
DHHS management expects this new system to alleviate issues experienced with 
the current system.  
Current Cost Containment Measures for DME 
OMS has undertaken 
several initiatives to 
contain costs for DME by 
securing better pricing or 
verifying medical necessity 
for items in advance of 
vendors supplying them to 
MaineCare members. 
In March 2010, the State 
will be contracting with a 
third party administrator 
to process claims and this 
will involve transitioning 
from MECMS to a new 
claims processing system. 
During this review, the Office of MaineCare Services cited several initiatives that 
have been undertaken to control costs associated with DME.  These measures are 
either intended to secure better pricing or verify medical necessity for DME items 
being provided to MaineCare members.  These cost containment measures include:  
• Prior Authorization (PA).  This is the process where an assigned MaineCare 
employee formally reviews requests for services or goods to be provided to 
a MaineCare member by a specific vendor.  An approval must be granted 
before the service or good is administered or delivered to the member.  The 
MaineCare Benefits Manual specifies when PA is required, which includes 
all transactions in excess of $499.99.  In addition, many pieces of durable 
medical equipment require PA for any transaction, regardless of cost.   The 
only exception to the PA rules is when Medicare is the primary payer and 
MaineCare is the secondary payer for a member.  In these cases, PA is not 
required.  DME transactions that require PA, but do not have a PA number 
in MECMS when the claim is processed are denied.  However, OPEGA did 
discover a MECMS programming error that allowed claims to be paid after 
the PA was voided.  See Recommendation 9 for discussion.  
• Bulk Purchase Contracts.  OMS continues to pursue bidding out entire 
categories of products and awarding contracts to single manufacturers, thus 
securing the best rates possible for the State.  Vendors purchase items from 
the contracted manufacturer at the rate negotiated by the State and pass on 
these lower rates to the MaineCare program when they submit claims.  
Historically, eyeglasses and incontinence supplies have been contracted 
with single manufacturers and, during the course of this review, bids were 
being solicited and received for bent metal (canes, crutches, walkers), 
ostomy supplies, and wound care supplies. 2  OPEGA has documented 
several issues that limit DHHS’ ability to ensure that the State does not pay 
vendors more than the contracted rates on items covered by bulk purchase 
contracts.  The State’s current contract for incontinence supplies is with the 
manufacturer Invacare and OPEGA identified potential overpayments to 
vendors on items covered by this contract.   See Recommendations 1, 3, 4, 
and 7 for more discussion. 
                                                 
2 Eyeglasses are not considered DME as per the MaineCare Benefits Manual.  Consequently, 
OPEGA did not test for any overpayments associated with these items. 
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• Multi-State Purchasing.   Maine participates in the New England States 
Consortium Systems Organization (NESCSO).  This organization is 
working to get multi-state, bulk purchasing in place to reduce durable 
medical equipment costs for New England states.  This effort is currently in 
progress and may have potential for future cost containment in other non-
DME areas. 
• Limits on Quantities.   While this review was in progress, DHHS proposed, 
and the Legislature approved, an amendment to MaineCare rules that 
establishes limits on monthly allowances for items covered by the Invacare 
contract.  Previously, the rule stated that vendors could not bill for more 
than a 34 day supply of an item for a given member.  The quantity needed 
for a 34 day supply, however, was determined by vendors—who profit 
from these transactions—and varied significantly from member to member.  
The new quantity limits will help ensure that MaineCare does not incur 
unnecessary expenses by allowing stronger automated edits and checks to 
be built into the claims processing system.  It is important to note, 
however, that these limits do not prevent members from receiving needed 
goods as quantities exceeding monthly limits may be approved through the 
PA process.  
The Office of MaineCare Services reported that it had also explored purchasing 
durable medical equipment and medical supplies direct from manufacturers, but 
found that this would be a poor fit for the MaineCare program.  The MaineCare 
Benefits Manual requires that all MaineCare vendors of durable medical equipment 
have a storefront for the sales and service of the supplies and equipment sold.  This 
is to ensure that those members using these products have access to the service, 
training, and education associated with the use of such goods.  These critical 
customer service elements would not be provided if purchases were made directly 
from manufacturers.  
Audits and Monitoring of MaineCare Claims 
The MaineCare program is subject to several regular audits in which samples of 
MaineCare claims are examined for compliance with various aspects of federal and 
State requirements.  None of these audits focus specifically on durable medical 
equipment and medical supplies, but claims for DME items may be included in the 
samples of claims reviewed.  These audits are: 
• The State Single Audit of the federal Medicaid program and SCHIP 
conducted annually by the State Auditor.  This audit typically focuses on 10 
to 12 specific areas within those programs and includes testing of some 
claims paid with federal funds to ensure compliance with federal 
requirements. 
• The Payment Error Results Measurement (PERM) audit, which is a federal 
audit required by law.  The audit is conducted by CMS to determine the 
accuracy of Medicaid and SCHIP claims payments and the accuracy of 
eligibility determinations made by the State. 
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MaineCare claims are 
audited and monitored by 
several entities including 
federal CMS, OMS, the 
State Audit Department, 
and the Program Integrity 
Unit.  None of these 
efforts focus specifically 
on DME, but DME claims 
may be included in 
samples of claims 
selected for review. 
• A monthly audit performed by the Office of MaineCare Services’ Quality 
Assurance group that selects 50 cases where eligibility was granted and 14 
cases where it was denied to check the appropriateness of eligibility 
determinations made by staff. 
• A quarterly audit performed by the Office of MaineCare Services’ Quality 
Assurance group that, according to management, is the most likely to 
include some DME claims.  In this audit, 200 claims per quarter are 
selected including 190 randomly selected claims and the ten highest paid 
claims for the quarter.  These claims are reviewed for compliance in the 
following areas: 
− Eligibility 
− Third Party Liability Billing 
− Appropriate Procedure Codes 
− Correct Reimbursement Rates 
− Quantity Limits (if applicable) 
− Prior Authorization 
− Co-Pays 
− Medical Necessity 
− Accounting Strings (ensuring that claims are paid from the correct 
accounts) 
− Vendor Eligibility For Procedure Code Used 
Any errors found are categorized as to cause of the error and 
communicated to the Commissioner.  They are also forwarded, as 
appropriate, to DHHS’ Program Integrity Unit for potential further 
investigation and/or the Third Party Liability group to make any 
appropriate adjustments.  
The Program Integrity Unit also monitors and reviews MaineCare claims with a 
focus on identifying, investigating and recovering losses from fraud, abuse or 
overpayments to providers.  PIU sends out recoupment letters to providers when it 
determines that overpayments or payments on inappropriate claims have occurred.  
In discussions with PIU, OPEGA learned that the Unit has been hampered by the 
lack of a functioning SURS (Surveillance and Utilization Review) system since 
1995.  We also learned that there is no formal reporting of issues identified by PIU 
to managers who can take action to help prevent future program losses.  See 
Recommendations 1 and 2 for further discussion. 
In addition to these audits, the Department’s Budget and Planning Group performs 
high-level trend analysis of billings by procedure code.  This group examines the 20 
highest paid specialties and the procedure codes within these specialties to track 
changes in usage.  While not specifically targeted to durable medical equipment and 
medical supplies, it is a high level of oversight that may incorporate this category of 
products to some degree.  
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Conclusion ―――――――――――――――――――――――――――――――――
Existing measures for preventing and detecting excessive, unnecessary or 
inappropriate claims need to be strengthened to more effectively control costs and 
better support DHHS’ cost containment initiatives for MaineCare DME.  
Currently, efforts to control costs are significantly hindered by: 
We also identified 
numerous situations that 
appeared to present risk 
of fraud or unnecessary 
expenditures.  These are 
currently being researched 
by DHHS to determine 
whether any actual loss 
has occurred. 
Our analysis of claims 
identified $115,900 in 
potential overpayments in 
FY08.  We roughly 
estimate that there could 
be an additional 
$229,000 for FY09.   
OPEGA concluded that 
existing measures for 
preventing and detecting 
excessive, unnecessary or 
inappropriate claims need 
to be strengthened.  The 
State is not realizing the 
full benefit of its cost 
containment efforts. 
• weaknesses in automated system edits and checks; 
• lack of a process for routine analysis and identification of transactions that 
present risk for fraud or unnecessary expenditures; and 
• lack of communication and coordination among DHHS units. 
As a result of these issues, the State is also not realizing the full benefit of its cost 
containment efforts.  For example, OMS signed a bulk purchase contract with the 
manufacturer Invacare to allow vendors to purchase incontinence supplies at a 
reduced price.  Savings are supposed to be passed on to the MaineCare program 
when the vendor submits claims.  However, for multiple reasons, the control in 
MECMS intended to prevent payment of claims that exceed the contracted rate is 
ineffective and, consequently, there is substantial risk that MaineCare will end up 
paying more than necessary for the items under contract. 
Acting on a concern raised by a DHHS employee, PIU did recently review 
transactions related to the Invacare contract and identified over $400,000 in 
overpayments to vendors for claims paid between January 2005 and December 
2007.  Ideally, DHHS’ Program Integrity Unit would have identified and 
investigated potential overpayments such as this as part of a routine, systematic 
monitoring of MaineCare claims, but PIU has not had a functioning Surveillance 
and Utilization Review System (nor an adequate substitute) for the past 14 years.   
PIU also identified the inconsistency in billed quantities as a primary root cause of 
the overpayments.  This issue remained unaddressed at the time of our review, 
however, because a formal process for communicating such issues to those with 
authority to take action did not exist.  As a result, it appears that overpayments 
have continued.  
OPEGA’s own analysis of transactions identified $115,900.70 in potential 
overpayments or unnecessary expenditures during FY08 from the continuing 
overpayments on the Invacare contract and other ineffective controls.  Since the 
root causes remain unaddressed, we roughly estimate that there could be an 
additional $229,000 in losses that have occurred between July 1, 2008 and June 30, 
2009.   
In addition, we identified numerous situations that appeared to present risk of 
fraud or unnecessary expenditures.  Thirty-four of these situations have been 
shared with DHHS and are being researched by the Program Integrity Unit to 
determine whether any actual losses have occurred.  Sixteen others are being 
researched by the Office of MaineCare Services. 
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The Recommendations section of this report has a full discussion of the issues 
identified during this review, some of which also have implications for non-DME 
MaineCare claims.  The Agency Response section of the report describes the 
actions DHHS plans to take in response to those recommendations.  DHHS 
expects that many of the issues OPEGA identified will be resolved for future 
periods with the implementation of the new MIHMS.  Consequently, we also 
recommend, in general, that the new MIHMS and the processes established by the 
third party administrator be audited at a future date to ensure that these issues do 
not continue after the transition in March 2010.   
Recommendations ―――――――――――――――――――――――――――――
 Strengthen the Program Integrity Unit’s Capacity to Monitor 
MaineCare Claims  
For the last 14 years, DHHS’ Program Integrity Unit (PIU) has not been 
conducting routine, systematic monitoring of MaineCare expenditures for 
indicators of potential fraud or unnecessary expenditures.  According to DHHS, 
the Surveillance and Utilization Review System (SURS) that was used to flag 
suspect transactions for investigation ceased functioning in 1995 as a result of a 
computer system failure.  DHHS chose not to expend resources to restore it at that 
time.  The new Maine Claims Management System (MECMS) that went into 
production in 2005 was supposed to include a SURS module, but that functionality 
was never developed.   
The PIU reports that it has compensated somewhat by enlisting the help of Office 
of MaineCare Services’ staff with strong database knowledge to occasionally 
generate simple reports through queries of the claims system databases.  Creating 
such queries, however, is described as quite complex and time-consuming and 
consequently much of the Unit’s work has been generated by inquiries or “tips” 
from both internal and external sources. 
This practice appears to have produced leads and resulted in the recouping of 
substantial overpayments from providers.  However, there may be other program 
losses that have gone undetected without routine, systematic monitoring to flag 
questionable claims activity.  As noted in Recommendation 6, OPEGA’s own 
analysis of FY08 MECMS claims for MaineCare members receiving DME 
identified numerous situations that had indicators of fraud or unnecessary 
expenditures.   
Recommended Management Action:   
The PIU expects routine, systematic monitoring of MaineCare transactions to once 
again become the standard for the Unit with the March  2010 implementation of 
the new claims processing system, MIHMS.  The new system will include JSURS, a 
healthcare fraud and abuse identification analysis and reporting system that should 
address past deficiencies in system capabilities.  OPEGA also recommends that 
DHHS take any additional steps necessary to ensure that the PIU is poised to make 
1 
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effective and efficient use of the information that will be generated by JSURS 
including adequate staffing, training and technical support. 
If successful implementation of JSURS does not occur or is significantly delayed, 
then the PIU should establish an alternative means of conducting routine, risk-
based monitoring of MaineCare claims as soon as possible.  OPEGA believes that 
a reasonable level of monitoring, similar to OPEGA’s analysis for this review, 
could be achieved using readily available applications like MS Access or Excel.  
OPEGA is also familiar with other relatively inexpensive off-the-shelf data analysis 
software that can be set up to run established analytical routines against files of 
transactions on a recurring basis.  
 Issues Identified by the Program Integrity Unit Need 
Communication and Action 
OPEGA found that the Program Integrity Unit has, in the past, identified control 
and policy issues that are root causes for overpayments on DME claims, but no 
action had been taken to address them.  The conditions resulting in the 
overpayments continue to exist, making it highly likely that MaineCare has 
continued to pay out more for certain DME items than is necessary.  (See 
Recommendations 3 and 7.)  Recoupment of any continuing overpayments 
currently appears to depend upon whether the PIU returns to examine MaineCare 
claims for these particular items in the future.    
Through further inquiry, we learned that there is no formal process in place to 
ensure that control and policy issues identified by the PIU are communicated to, 
and thoroughly understood by, those with authority and responsibility to address 
them.  For example, the inconsistency in billing units that has contributed to the 
overpayments on incontinence supplies described in Recommendation 3 was 
purportedly identified by the PIU as an issue back in the 1980’s.  OMS 
management did receive copies of the recent recoupment letters the PIU sent to 
vendors, but the PIU did not otherwise formally communicate to management the 
control and policy weaknesses or their ramifications.  At the time of our review, 
OMS management was still relatively unaware of the root causes of the 
overpayments on incontinence supplies or PIU’s suggestions for potential 
solutions. 
Recommended Management Action:   
DHHS should establish formal processes that provide for documentation of 
conditions identified by PIU as contributing to overpayments, fraud or unnecessary 
expenditures and communication of those issues to managers that can address 
them.  DHHS should also establish a system for tracking when and how the issues 
are addressed to ensure that appropriate action is taken to prevent future financial 
losses whenever possible.  
2 
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Correlate Units of Measure for Quantities Billed with Allowed 
Rates to Prevent Overpayments 
In analyzing DME claims, we discovered that quantities billed by vendors may vary 
as to the unit of measure and that the unit of measure is not specified by the 
vendor when submitting the claim. For example, the billed quantity for a box of 
100 non-sterile gloves could be: 
• 100 (to represent the number of individual gloves); 
• 50 (to represent the number of pairs of gloves); or 
• 1 (to represent the number of boxes of gloves). 
This variability in billed quantities impacts MECMS’ ability to prevent 
overpayments for DME items where members receive more than one of the item 
in a single container (i.e. gloves, disposal undergarments).  As shown in the 
example below, if the vendor bills for a quantity in a different unit of measure than 
the maximum rates are based on, there is risk of an underpayment or overpayment 
to the vendor.  It is likely that vendors would seek an adjustment for an 
underpayment, but perhaps not for an overpayment.  In fact, the Program Integrity 
Unit recently sought recoupment of $416,712.16 from 24 vendors for 
overpayments related to this issue.  See Recommendation 7.   
This situation also has ramifications for the PIU’s surveillance and utilization 
review activities.  The ability to use data existing in the system to efficiently identify 
only those claims that truly have potential for overpayment is limited, as is the 
ability to detect abnormal quantities that might indicate abusive billing practices.  In 
addition, determining whether there really has been an overpayment requires 
confirming with the vendor what unit of measure the billed quantity actually 
represents.  
 
Example – Maximum Allowed Reimbursement Calculation 
MECMS calculates the maximum allowed reimbursement amount for an item 
based on maximum rates for the applicable procedure codes and the quantity 
billed by the vendor.  The unit of measure the rate is based on is specified in the 
procedure code description.  Vendors, however, may not bill quantities in the same 
unit of measure and, consequently, MECMS calculates a significantly higher or 
lower maximum reimbursement amount. 
In the simplified example below, procedure code A4927 is for “gloves, non-sterile, 
per 100”.  If a vendor bills for a quantity of 500 (representing the number of 
individual gloves) rather than 5 (representing 5 boxes of 100 each), MECMS 
calculates a maximum reimbursement amount of $2,023 rather than the correct 
$20.23.  If the vendor’s claim amount exceeds $20.23, but is anything less than 
$2,023, the vendor will be paid for the full amount claimed. 
PROCEDURE 
CODE 
CONTRACTED 
MAXIMUM 
RATE INC. 
MARK UP 
QTY PER 
BOX 
BILLED 
SERVICE 
UNITS 
UPPER LIMIT 
CALCULATED 
BY MECMS 
5 $20.23 
A4927 $4.046/BOX 100 
500 $2,023.00 
3 
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Lastly, inconsistencies in the quantity data available in MECMS hinder DHHS’s 
ability to easily identify other DME items that might offer potential for savings 
through bulk purchasing.  It might also affect the ability to negotiate the best rates 
on such contracts. 
Recommended Management Action:   
DHHS should take steps to ensure that billed quantities from vendors can be 
correlated in an automated fashion to the unit of measure on which the maximum 
allowed rates are based.  Possible approaches to accomplishing this goal include: 
• Requiring quantities to be billed at the lowest unit of measure possible, i.e. 
each rather than box, and either establishing rates in the Rate Tables to be 
at the lowest unit of measure, or creating a process for converting the 
allowed rates to that unit of measure. 
• Creating a data field and requiring vendors to indicate the unit of measure 
represented by the billed quantities when submitting the claim.  The data 
field could perhaps be designed with a drop down selection of units of 
measure, i.e. each, pair, box, case.  The system could then be programmed 
to convert either the billed quantities or the rate if the unit of measure 
billed differed from what the rate was based on. 
• Using an existing data field in the claims system to establish a maximum 
quantity for each DME item based on the unit of measure anticipated in 
the rate coupled with what a MaineCare member might reasonably be 
expected to use within a certain time period.  The system could then be 
used to flag claims exceeding the maximum quantity for manual review 
prior to payment.  
OPEGA also recommends that DHHS ensure that the new MIHMS and related 
processes are appropriately designed to address this situation. 
Establish Contracted Rates for Items Under Bulk Purchase 
Agreements in Rate Tables 
In examining the MECMS Rates Tables, OPEGA discovered that the MaineCare 
rates for those procedure codes covered by the contract with Invacare did not 
match the negotiated rates.  DHHS confirmed that the current Rate Tables did not 
reflect the contracted rates. 
 
As a result, the MECMS control to limit reimbursement to vendors to the 
contracted rate – thereby ensuring cost savings are achieved - is ineffective.  For 
example, the highest contracted rate for latex gloves is $2.89 per box of 100 gloves.  
The MaineCare rate currently in MECMS—and used in determining the maximum 
reimbursement amount—is $25.00 per 100 gloves.  MECMS would, therefore, pay 
any claimed amount that was less than $25.00 per box. 
 
4 
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Recommended Management Action:   
The Department needs to establish procedures to ensure all contracted rates for all 
bulk purchasing agreements are entered into MECMS or MIHMS so that system 
controls are effective in supporting DME cost containment efforts.   
Address Procedure Code Modifiers in Rate Tables to Prevent 
Overpayments to Vendors 
The Rate Tables in MECMS currently contain two different active rates for DME 
items in new condition.  Consequently, the maximum allowed reimbursement to 
vendors could be based on either rate depending on the billing code used.  This 
situation, which has been resulting in overpayments to vendors since January 2008, 
went undetected until the time of our review. 
Annually, the federal CMS provides the Office of MaineCare Services with a data 
feed containing the updated federal reimbursement rates for goods and services.  
Each line in this data feed contains the procedure code for a given item (or service) 
along with a procedure description, the reimbursement rate, the dates to and from 
which the rate is applicable, and a modifier code. 
The modifier code allows for the distinction between a used, rented, or new DME 
item.  Historically, a modifier code of “UE” indicated used, “RR” indicated a 
rental, and no code (or “null” as it appears in the database) indicated an item in 
new condition.  These codes, as well as the other fields of the data feed, are shown 
in the excerpt from the MECMS Rate Tables included in the example below. 
For 2008, CMS issued a data feed in which a new modifier code—“NU”—was 
used to indicate a product in new condition.  MECMS did not recognize the lines 
with the “NU” modifier code as replacements for the earlier “null” rate (which was 
intended), but rather as completely different records.  Because the previous rates 
for DME items in new condition had an expiration date in the year 2999, both rates 
have been active since January 2008.   
This situation, as illustrated in the example below, presents the risk of 
overpayments because reimbursement rates for new DME items generally 
decreased from 2007 to 2008.  
Vendors submitting claims for these 
items with no modifier code, which 
had previously been the norm for new 
items, would receive the higher “null” 
reimbursement rate, rather than the 
intended—and lower—reimbursement 
rate with the “NU” modifier code.  
There were also instances where the 
reimbursement rates for a new item 
increased from 2007 to 2008 and in 
these instances vendors that billed with 
no modifier code would be underpaid. 
Example – Active Rates in MECMS Rate Table for Procedure Code E0110 
Modifier codes “null” and “NU” both are active rates in MECMS for an item in 
new condition.  Vendors billing without the “NU” modifier code would be paid a 
maximum of $77.21 (“null” code) on the claim.  They should, however, have 
been reimbursed at the most current $65.95 rate (“NU” code) and those 
reimbursed at the old $77.21 rate were overpaid. 
Procedure 
Code 
Procedure 
Description 
Modifier 
Code From Date To Date Rate 
E0110 Crutch forearm pair RR 1/1/2008 12/31/2008 13.59 
E0110 Crutch forearm pair UE 1/1/2008 12/31/2008 49.45 
E0110 Crutch forearm pair null 10/1/2002 12/31/2999 77.21 
E0110 Crutch forearm pair NU 1/1/2008 12/31/2008 65.95 
5 
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OPEGA’s analysis of MECMS claims for DME occurring between January 1, 2008 
and June 30, 2008 identified 1,884 transactions with total potential overpayments of 
$36,427.41.  We also identified potential underpayments totaling $1,328.35 on 297 
transactions.  These totals reflect only those transactions paid during the last six 
months of FY08.  FY09 has just concluded and this same issue (two active rates) 
has existed throughout its duration.  Assuming that vendors have not changed their 
billing practices and that the level of claims for new DME items has remained 
constant, we roughly estimate the net additional overpayments for July 1, 2008 
through June 30, 2009 to be $70,000. 
Recommended Management Action:   
DHHS should immediately inform vendors of the requirement to submit claims for 
new DME items with a “NU” modifier code and remove the records with active 
rates for “null” codes from the MECMS Rate Tables.  On an on-going basis, 
DHHS should periodically run exception reports, including after receiving a data 
feed from CMS, to identify and take action on any irregularities in the Rate Tables 
that would affect the system’s payment controls. 
6  Research Questionable Claims Activity Identified by OPEGA 
OPEGA’s analysis of DME claims included tests designed to identify claims or 
patterns of claim activity that met certain indicators for potential fraud or 
unnecessary expenditures.  As a result, thirty-four situations with higher potential, 
as per the number or nature of the indicators they met, have been referred to 
DHHS’ Program Integrity Unit for further research and sixteen have been referred 
to OMS.  These situations were not referred to DHHS until the end stages of this 
review and, as of the date of this report, the research is still in progress.  
Recommended Management Action:   
DHHS should complete its research into the questionable claims activity flagged by 
OPEGA.  The results of that research, including an estimate of any dollars 
associated with identified overpayments, fraud or unnecessary expenditures, should 
be reported to OPEGA and the Government Oversight Committee.  OPEGA 
would use these results to determine whether the remainder of transactions with 
similar indicators should be forwarded to the Department for further examination.  
OPEGA would also report to the GOC as to whether there are additional 
recommendations it would make for action on any problematic situations 
identified.   
DHHS should maintain adequate documentation of its research and results to 
allow OPEGA or another audit entity to validate the work and results if necessary.  
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 Investigate Possible Additional Overpayments For Incontinence 
Supplies 
7 Due to the situations described in Recommendations 2, 3 and 4, there has been a 
continuing risk of overpayments on incontinence supplies covered by the Invacare 
contract.  The PIU had previously identified $416,712.16 in overpayments during 
the period January 2005 through December 2007 and had sought recoupment from 
24 providers. 
OPEGA analyzed claims from January 1, 2008 to June 30, 2008, which was the 
portion of FY08 that the Program Integrity Unit had not already investigated.  
Payment amounts were reconciled with quantities and then compared to the 
corresponding rates established in the contract.  A total of $79,606.29 was 
identified as being potentially overpaid in that period.  We roughly estimate that 
there may be an additional $159,000 in overpayments for FY09 bringing total 
potential overpayments for the period January 2008 through June 2009 to nearly 
$239,000. 
Recommended Management Action:   
The Program Integrity Unit should review the potential additional overpayments 
identified by OPEGA, determine whether actual overpayment occurred and initiate 
recoupment from vendors as appropriate.  DHHS should report back to OPEGA 
and the GOC on the results of this research and any actions taken. 
Proactively Address Procedure Codes with Reimbursement Rates 
of Zero to Prevent Rejection of Vendor Claims 
The data feed from CMS, mentioned earlier, often includes procedure codes with a 
reimbursement rate of $0 which become established in the MECMS Rate Tables as 
the maximum allowable rate.  According to OMS, these are errors but the Office 
currently does not have a process for proactively identifying these situations and 
correcting them.  Consequently, any vendor claims submitted for these procedure 
codes are rejected as they exceed the maximum reimbursement rate.  Vendors must 
then make inquiries about the rejected claims.  After receiving a complaint, OMS 
determines whether or not to cover the specific item and has DHHS’ Rate Setting 
Unit establish an allowable rate. 
OMS reports that many of the procedure codes with $0 maximum rates are not 
used in vendor claims and, therefore, claim rejections for this reason are not 
frequent.  OPEGA has not assessed the actual frequency or impact but it does 
appear that, at the very least, the current reactive approach to $0 rate errors likely 
results in extra steps and delayed payments for vendors who do bill for any of these 
procedure codes. 
Recommended Management Action:   
Exception reports should be run periodically (such as after a data feed is received 
from CMS) to identify procedure codes with reimbursement rates of zero.  
8
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Decisions on whether or not to cover these DME items and the determination of 
appropriate rates should then be made proactively to eliminate needless rejected 
claims for vendors.  
9
Correct Programming Error to Ensure Transactions Without 
Required Prior Authorization Are Not Paid 
OPEGA tested a sample of DME claims that appeared to have been paid without 
the required prior authorization (PA).  In doing so, we identified one transaction 
for which OMS could not provide a reasonable explanation.  Further research by 
the Office of Information Technology discovered a MECMS programming error 
that allowed a payment of $1,195.35 on the transaction after OMS staff had voided 
the PA on the system. 
It appears OMS staff initially granted the PA in error, realized this error, and 
voided the PA in the same day.  Although it is likely that instances of this scenario 
are few, the potential does continue to exist that claims with PA that have been 
voided within a particular time frame will be paid.   
Recommended Management Action:   
The Department should correct the programming error in MECMS and ensure that 
a similar error does not exist in the new MIHMS system slated for implementation 
on March 1, 2010. 
Agency Response   ――――――――――――――――――――――――――――― 
OPEGA discussed the preceding findings and recommendations with the 
Department of Health and Human Services in advance and provided an 
opportunity for the Department to submit their own planned management actions 
in response to those recommendations.  The management actions provided by 
DHHS are detailed in this section, and are numbered to correspond with the issues 
described by OPEGA in the Recommendations section of the report. 
DHHS actions on some of the recommendations have been underway during the 
time period that this report was being finalized.  Due to timing, OPEGA has not 
had an opportunity to assess whether those actions are adequate to fully address 
the issues identified and make any appropriate adjustments to reported 
recommendations. Consequently, review of these actions will be incorporated into 
the normal report follow up process.  
In accordance with 3 MRSA §996, OPEGA also provided the Department of 
Health and Human Services an opportunity to submit additional comments on the 
draft of this report.  
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Strengthen the Program Integrity Unit’s Capacity to Monitor MaineCare 
Claims  1 
The JSURS tool provided by the new Fiscal Agent will address this issue with 
regular reports.  JSURS will be implemented March 1, 2010.  In the meantime, two 
quarterly reports are being developed to enable the Program Integrity Unit to 
actively monitor per unit pricing and number of units purchased and follow up on 
any spikes or unusual patterns that may indicate fraud and abuse.  Each report will 
provide the number of units billed, the number of units paid, and the amount paid 
per unit.  One report will provide this information by dealer and the other will be 
by member.  The first reports which cover the last quarter of FY09 are expected in 
August 2009 and then will be generated monthly thereafter. 
 Issues Identified by Program Integrity Unit Need Communication and 
Action 2 
As of July 14, 2009, the Program Integrity Unit has instituted bi-weekly staff 
meetings to discuss cases and identify issues that require a systems review or 
adjustment.  A list of the issues identified will be prepared and communicated to 
the appropriate units within DHHS and other State agencies.  In this way, issues or 
concerns that could be detrimental to the MaineCare program, either financial or 
programmatic, are highlighted for attention.  
Overpayments that are identified by PIU will also be recorded, tracked and pursued 
for collection through the processes and structure that have been recently created 
for such purposes. 
3 
Correlate Units of Measure for Quantities Billed with Allowed Rates to 
Prevent Overpayments 
The new MIHMS system will require that the number of units and unit cost 
information (i.e. 10 diapers at $0.77 each) be entered for every purchase, and an 
upper limit will be established for the number of units that may be billed at one 
time.  A project team is working to establish billing and unit limits, which will be 
implemented in MIHMS to prevent potential excessive billing.  That work will be 
complete by August 15, 2009 and MIHMS will be implemented March 1, 2010.  In 
the meantime, the quarterly reports being developed in response to 
Recommendation 1 should help identify potential overpayments related to this 
issue. 
4 
Establish Contracted Rates for Items Under Bulk Purchase Agreements in 
Rate Tables 
The incontinent supply contract has recently been renewed and new rates will be 
effective as of August 1, 2009.  All new contracted rates will be entered into the 
system Rate Tables by then.  The new limits on quantity of these items that can be 
supplied for a particular time period will also go into effect on August 1, 2009.  
Vendor compliance with these limits will need to be manually monitored until 
MIHMS is implemented March 1, 2010.  
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In addition, DHHS has implemented a reporting process to monitor billing (claims) 
submitted by vendors using data collected through the contracted manufacturer. 
These reports will go to the contract manager and are meant to work in 
conjunction with the reports developed in response to Recommendation 1.  These 
reports will allow staff to compare utilization by distributor, dealer and member. 
The reports are required by the contract terms and conditions and the first report is 
due September 7, 2009.  
5 
Reconcile Procedure Code Modifiers in Rate Tables to Prevent 
Overpayments to Vendors 
A quarterly report has been developed to show any null modifier codes and $0 rate 
values in the MECMS Rate Tables so they can be reviewed and corrected in the 
system.  The first of these reports has been run and, hereafter, will be generated 
quarterly following the receipt of the CMS rate list.  The report will be manually 
reviewed and items identified will either be recoded in MECMS or eliminated.  This 
issue is expected to be resolved under MIHMS which will not allow blank fields.  
In the meantime, instructions will go out to the vendors that they must use the 
“NU” modifier and rate for items in new condition. 
Research Questionable Claims Activity Identified by OPEGA 
6 The Program Integrity Unit has completed its initial review of 18 of the 34 
situations referred to it that OPEGA had identified as possibly representing cases 
of fraud or unnecessary expenditures.  As a result, PIU determined there was a total 
of $7,726 in overpayments on five of these situations and has initiated recovery as 
appropriate which included recoupment of overpayments or vendor adjustments of 
the claims.  In addition, PIU determined that four of the other 18 situations 
warrant a more detailed examination and those examinations are in progress. PIU 
has begun review of the remaining 16 situations referred and will seek clarification 
from OPEGA on the specific concerns related to them as necessary in determining 
how to proceed. 
The Office of MaineCare Services has also completed its review of the 16 situations 
referred to it.  Reasonable explanations existed for the questions raised by OPEGA 
and none of the situations were deemed to represent instances of fraud or 
unnecessary expenditures. 
DHHS will provide periodic updates on the progress and results of actions taken 
on this recommendation to OPEGA and the Government Oversight Committee 
beginning in September 2009.  
7 
Investigate Possible Additional Overpayments for Incontinence Supplies 
The majority of overpayments previously identified by the Program Integrity Unit 
audit have been collected.  OPEGA had identified approximately 6,000 claims with 
potential additional overpayments in the period from January 1, 2008 to June 30, 
2008.  PIU continues to work with OPEGA to prioritize those claims.  PIU will 
then evaluate the return on investment in devoting limited staff resources to 
investigating these claims and proceed as appropriate.  DHHS will provide periodic 
updates on PIU actions taken on this recommendation and related results to 
OPEGA and the Government Oversight Committee beginning in September 2009.  
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8 
Proactively Address Procedure Codes with Reimbursement Rates of Zero to 
Prevent Rejection of Vendor Claims 
A quarterly report has been developed to show any null modifier codes and $0 rate 
values in the MECMS Rate Tables so they can be reviewed and corrected in the 
system.  The first of these reports has been run, corrections are in progress and are 
expected to be complete by August 7, 2009.  Hereafter reports will be generated 
quarterly following the receipt of the CMS rate list.  The reports will be manually 
reviewed and items identified will either be recoded in MECMS or eliminated.   
Correct Programming Error to Ensure Transactions Without Required Prior 
Authorization Are Not Paid 9 
This issue was the result of a MECMS failure that permitted the payment of a claim 
even after the PA had been cancelled.  PA’s must occasionally be cancelled if, for 
instance, a PA is issued to the wrong Provider ID.  In MECMS, when a PA is 
cancelled the record remains in the system (with the status “cancelled”), and a new 
PA is issued to the correct Provider ID.  However, the system should never pay a 
claim to a cancelled PA.   
The MIHMS PA process will be in place on March 1, 2010 and eliminates this 
issue.  
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